A study by Bai et al. [43] suggested that IRF1 and IRF8 might be potential regulators of the SPHK1 (the sphingosine pathway promotes vascular remodeling and induces PAH) overexpression gene set signature in human PASMCs. This evidence concerns the gene SPHK1 and pulmonary arterial hypertension.